Product Information
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $79.5342 per EA under NDC 00093356026. Its NADAC has been published 307 times since Nov 18, 2020.
FDA first approved this application on Jan 25, 2012. Its Orange Book therapeutic-equivalence code is AA.
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACIDManufacturer
Teva Pharmaceuticals USA Inc.NDC
00093356026
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090145FDA Approved
1/25/2012
TE Code
AA
On Market Since
8/31/2020
Price Statistics
The NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has been published 307 times since Nov 18, 2020, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $79.5342 per EA |
|---|---|
| All-time high | $91.4380 (Jan 12, 2022) |
| All-time low | $52.1485 (Jul 17, 2024) |
| 52-week high | $82.3268 |
| 52-week low | $70.9860 |
| Median price | $78.1950 |
| Average price | $78.6869 |
| Largest weekly change | -33.1% (Jul 17, 2024) |
| Weeks tracked | 307 |
| Tracking since | Nov 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
The current National Average Drug Acquisition Cost (NADAC) for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G, manufactured by Teva Pharmaceuticals USA Inc., is $79.5342 per EA (NDC 00093356026), effective Sep 30, 2026.
How has the price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G changed over time?
Over the history we have for it, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has declined 9.9%. It has been tracked across 307 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
Since Nov 18, 2020, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has ranged from a low of $52.1485 (Jul 17, 2024) to a high of $91.4380 (Jan 12, 2022), with a median of $78.1950 per EA.
Are there cheaper alternatives to PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
No other NADAC-published product currently shares the active ingredient and strength of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G (NDC 00093356026) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.